Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution

Virology. 1991 Nov;185(1):195-205. doi: 10.1016/0042-6822(91)90767-6.

Abstract

In a study on the evolution of genomic diversity of HIV-1, genomic RNA was isolated from serum of two individuals. Starting at the time of primary infection we collected six samples of serum from each patient over a period of 5 years. Ninety-four cDNA clones (50 of patient 1 and 44 of patient 495) of part of the envelope coding region including the principal neutralization domain (PND) were sequenced. Around the time of antibody seroconversion, genomic RNA levels reached a peak and the population of sequences was highly homogeneous. In the course of the infection, the number of amino acid substitutions accumulated, which led to a higher genomic diversity within successive samples and a drift in the consensus sequence, progressively differing from the first found consensus sequence. Fixation of a substitution at glycoprotein 120 amino acid 308 was observed in both patients between two time points (patient 1, H----P; patient 495, P----H). With the use of 16-meric synthetic peptides, differing only at the 308 position (H308 versus P308), antibody binding specificity was found to be dependent on this difference. In patient 495, the nonconservative (P308----H) substitution reduced the binding affinity with the patient's antibodies. Furthermore, antibody competition assays showed that the observed substitution at position 308 elicited a new antibody population, indicating antigenic variation. After the decline of V3-specific antibodies, the simultaneous increase in genomic RNA levels and progression to AIDS in patient 495, a new variant with major changes in the PND emerged, again forming a homogeneous population of sequences.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome / blood
  • Acquired Immunodeficiency Syndrome / immunology
  • Acquired Immunodeficiency Syndrome / microbiology*
  • Amino Acid Sequence
  • Antibody Formation
  • Antigenic Variation*
  • Base Sequence
  • Cloning, Molecular
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Genes, Viral*
  • HIV-1 / genetics*
  • HIV-1 / immunology
  • HIV-1 / isolation & purification
  • Homosexuality
  • Humans
  • Immunoglobulin G / immunology
  • Leukemia Virus, Bovine / genetics
  • Molecular Sequence Data
  • Mutation*
  • Oligodeoxyribonucleotides
  • Peptides / chemical synthesis
  • Polymerase Chain Reaction / methods
  • RNA, Viral / genetics*
  • Sequence Homology, Nucleic Acid

Substances

  • Immunoglobulin G
  • Oligodeoxyribonucleotides
  • Peptides
  • RNA, Viral

Associated data

  • GENBANK/M74591
  • GENBANK/M74592
  • GENBANK/M74593
  • GENBANK/M74594
  • GENBANK/M74595
  • GENBANK/M74596
  • GENBANK/M74597
  • GENBANK/M74598
  • GENBANK/M74599
  • GENBANK/M74600
  • GENBANK/M74601
  • GENBANK/M74602
  • GENBANK/M74603
  • GENBANK/M74604
  • GENBANK/M74605
  • GENBANK/M74606
  • GENBANK/M74607
  • GENBANK/M74608
  • GENBANK/M74609
  • GENBANK/M74610
  • GENBANK/M74611
  • GENBANK/M74612
  • GENBANK/M74613
  • GENBANK/M74614
  • GENBANK/M74615
  • GENBANK/M74616
  • GENBANK/M74617
  • GENBANK/M74618
  • GENBANK/M74619
  • GENBANK/M74620